Myers, L. K., Cullins, D. L., Park, J., Yi, A., Brand, D. D., Rosloniec, E. F., . . . Kang, A. H. (2015). Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization. Clinical immunology (Orlando, Fla.), 160(2), 188. https://doi.org/10.1016/j.clim.2015.05.002
Chicago ZitierstilMyers, Linda K., David L. Cullins, Jeoung-Eun Park, Ae-Kyung Yi, David D. Brand, Edward F. Rosloniec, John M. Stuart, und Andrew H. Kang. "Peptide Ligand Structure and I-Aq Binding Avidity Influence T Cell Signaling Pathway Utilization." Clinical Immunology (Orlando, Fla.) 160, no. 2 (2015): 188. https://dx.doi.org/10.1016/j.clim.2015.05.002.
MLA ZitierstilMyers, Linda K., et al. "Peptide Ligand Structure and I-Aq Binding Avidity Influence T Cell Signaling Pathway Utilization." Clinical Immunology (Orlando, Fla.), vol. 160, no. 2, 2015, p. 188.